Influence of formulation variables in transdermal drug delivery system containing zolmitriptan

被引:32
|
作者
Subedi, Robhash Kusam [1 ]
Ryoo, Je-Phil
Moon, Cheol
Choi, Hoo-Kyun [1 ]
机构
[1] Chosun Univ, Coll Pharm, Project Team BK21, Kwangju 501759, South Korea
关键词
Zolmitriptan; Transdermal drug delivery; Percutaneous penetration; Chemical enhancers; Polymorphism; Crystallization inhibitor; CRYSTALLIZATION; PERMEATION; ADHESIVES; ENHANCERS; MATRIX; SKIN;
D O I
10.1016/j.ijpharm.2011.08.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of different formulation variables including pressure sensitive adhesive (PSA), thickness of the matrix, solvent system, inclusion of crystallization inhibitor, loading amount of drug and enhancers on the transdermal absorption of zolmitriptan were investigated. Acrylic adhesive with hydroxyl functional group provided good adhesion force and high flux of zolmitriptan. Pseudopolymorphs of zolmitriptan were found to possess different solid-state properties that affected the permeation rate. Polyoxyethylene alkyl ethers significantly increased the permeation of zolmitriptan through hairless mouse skin. However, these enhancers induced crystallization of zolmitriptan. Kollidon (R) 30 delayed the crystallization without altering the permeation profile of zolmitriptan. Stability studies suggested that terpenes did not induce crystallization of zolmitriptan in the patch and stable formulations could be produced by using cineole and limonene, or their combination. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 50 条
  • [41] Formulation and In vitro Evaluation of Carvedilol Transdermal Delivery System
    Aparna, Pisipati
    Divya, Lyadella
    Bhadrayya, Kalva
    Subrahmanyam, Chavali V. S.
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2013, 12 (04) : 461 - 467
  • [42] Formulation, Optimization, and In vivo Evaluation of Clozapine Loaded Transdermal Drug Delivery System for the Treatment of Schizophrenia
    Agrawal, Milan B.
    Patel, Mayur M.
    ASIAN JOURNAL OF PHARMACEUTICS, 2020, 14 (04) : 556 - 571
  • [43] New insight into transdermal drug delivery with supersaturated formulation based on co-amorphous system
    Hirakawa, Yuya
    Ueda, Hiroshi
    Miyano, Tetsuya
    Kamiya, Noriho
    Goto, Masahiro
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 569
  • [44] Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system
    Venkata Ramana Malipeddi
    Rajendra Awasthi
    Daniela Dal Molim Ghisleni
    Marina de Souza Braga
    Irene Satiko Kikuchi
    Terezinha de Jesus Andreoli Pinto
    Kamal Dua
    Drug Delivery and Translational Research, 2017, 7 : 66 - 76
  • [45] Development of cataplasmic transdermal drug delivery system containing eutectic mixture of lidocaine and prilocaine
    Chun M.-K.
    Hossain K.
    Choi S.-H.
    Ban S.-J.
    Moon H.
    Choi H.-K.
    Journal of Pharmaceutical Investigation, 2012, 42 (3) : 139 - 146
  • [46] Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system
    Malipeddi, Venkata Ramana
    Awasthi, Rajendra
    Ghisleni, Daniela Dal Molim
    Braga, Marina de Souza
    Kikuchi, Irene Satiko
    Andreoli Pinto, Terezinha de Jesus
    Dua, Kamal
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2017, 7 (01) : 66 - 76
  • [47] TRANSDERMAL DRUG DELIVERY SYSTEM (TDDS): AN OVERVIEW
    Tyagi, R. K.
    Chandra, A.
    Singh, D.
    Rahman, Md. A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (06): : 1379 - 1388
  • [48] Development of albuterol transdermal drug delivery system
    Chen, SJ
    Kuo, CC
    Jiang, TS
    Cheng, CH
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 208 - 209
  • [49] OPTIMIZATION TECHNIQUES IN TRANSDERMAL DRUG DELIVERY SYSTEM
    Deshwal, Shikha
    Verma, Navneet
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (08): : 2362 - 2370
  • [50] Drug delivery to the eye with a transdermal therapeutic system
    Isowaki, A
    Ohtori, A
    Matsuo, Y
    Tojo, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (01) : 69 - 72